Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents

Neurochem Res. 1986 Jun;11(6):891-912. doi: 10.1007/BF00965212.

Abstract

The two 3H-labeled agonists [3H]8-hydroxy-2-(di-n-propylamino) tetralin ([3H]8-OH-DPAT) and [3H]serotonin ([3H]5-HT) have been used to examine the effects of physico-chemical parameters and modulatory agents on the high affinity 5-HT receptor binding sites in various regions of the rat central nervous system. Sites labeled by [3H]8-OH-DPAT and [3H]5-HT were differentially sensitive to changes in incubation temperature and pH, such that the optimal interaction of [3H]8-OH-DPAT with specific sites in the striatum was at 30 degrees C and pH 7.4, whereas [3H]5-HT sites in the same region were most easily labeled at 2-23 degrees C and pH 8.2. Micromolar concentrations of Mn2+ enhanced [3H]5-HT binding but inhibited markedly [3H]8-OH-DPAT binding to striatal membranes. In contrast, both [3H]5-HT and [3H]8-OH-DPAT binding were increased by the cation in hippocampal membranes. Conversely, GTP reduced the binding of either ligand in the hippocampus but affected only [3H]5-HT binding in the striatum. Furthermore, N-ethylmaleimide inhibited equally [3H]5-HT and [3H]8-OH-DPAT binding to hippocampal membranes, but was markedly less potent against [3H]8-OH-DPAT binding to striatal membranes. These results led to the definition of assay conditions for studying separately [3H]8-OH-DPAT binding to "hippocampal-like" (HL) and "striatal-like" (SL) sites. [3H]8-OH-DPAT HL binding sites were particularly abundant in the hippocampus, septum and cerebral cortex, and exhibited pharmacological properties typical of the postsynaptic 5-HT1A subsites previously characterized with [3H]5-HT as the ligand. The regional distribution of [3H]8-OH-DPAT SL binding sites was strikingly different from that of HL sites, but similar to that of serotoninergic terminals identified by their capacity to take up [3H]5-HT. The selective lesion by 5,7-dihydroxytryptamine of serotoninergic projections induced a marked loss of [3H]8-OH-DPAT SL binding sites in the striatum and the cerebral cortex, indicating that these sites were located presynaptically. In contrast, [3H]5-HT binding sites remained unchanged in lesioned rats, which confirmed further their exclusive postsynaptic location in brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5,7-Dihydroxytryptamine / pharmacology
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Animals
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Guanosine Triphosphate / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hydrogen-Ion Concentration
  • Kinetics
  • Male
  • Manganese / pharmacology
  • Naphthalenes / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Neurotransmitter / analysis
  • Receptors, Neurotransmitter / classification*
  • Receptors, Neurotransmitter / drug effects
  • Receptors, Serotonin / analysis
  • Receptors, Serotonin / classification*
  • Receptors, Serotonin / drug effects
  • Sulfhydryl Reagents / pharmacology
  • Temperature
  • Tetrahydronaphthalenes / metabolism*

Substances

  • Naphthalenes
  • Receptors, Neurotransmitter
  • Receptors, Serotonin
  • Sulfhydryl Reagents
  • Tetrahydronaphthalenes
  • 5,7-Dihydroxytryptamine
  • Manganese
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Guanosine Triphosphate